The National Cancer Institute proclaims GHS Cancer Institute among nation’s best in research. Greenville Health System’s Cancer Institute has been awarded $6.7 million to conduct clinical trials and research studies aimed at improving patient outcomes and reducing health disparities. GHS is the only community-based site in S.C. to receive the award. Clinical trials will focus on improving cancer prevention, cancer control, screening for early cancers, and post-treatment surveillance, while cancer care delivery research will focus on quality of life and understanding the diverse and multi-level factors that affect access to and quality of care.
The Cancer Institute of Greenville Health System (GHS) is dedicated to enhancing our communities’ quality of life through clinical excellence and research. Our core philosophy is anchored in providing the most effective cancer care available in the world. We understand that cancer care is about comfort, compassion and enhanced access to care, so we focus on treating the whole person, not just the disease. This means patients do not have to leave the Upstate to receive high quality cancer care. In fact, many people travel to GHS Cancer Institute from outside the state to receive care. Watch a short video to learn more about the outstanding diagnostics, treatment, rehabilitation and research options available through the GHS Cancer Institute.
The GHS Cancer Institute is accredited by the American College of Surgeons Commission on Cancer and is affiliated with the National Cancer Institute. It is also accredited by the Commission on Cancer and is the only academic comprehensive cancer care program in South Carolina.